
Aradhana Sasan
Examiner (ID: 9005, Phone: (571)272-9022 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 1310 |
| Issued Applications | 752 |
| Pending Applications | 117 |
| Abandoned Applications | 467 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14199125
[patent_doc_number] => 10266656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-23
[patent_title] => Silicone compounds and compositions thereof for the treatment of amino acid based substrates
[patent_app_type] => utility
[patent_app_number] => 15/512623
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25248
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512623
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512623 | Silicone compounds and compositions thereof for the treatment of amino acid based substrates | Sep 21, 2015 | Issued |
Array
(
[id] => 10654831
[patent_doc_number] => 20160000975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'LOCAL DELIVERY OF WATER-SOLUBLE OR WATER-INSOLUBLE THERAPEUTIC AGENTS TO THE SURFACE OF BODY LUMENS'
[patent_app_type] => utility
[patent_app_number] => 14/852790
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12788
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852790
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/852790 | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens | Sep 13, 2015 | Issued |
Array
(
[id] => 10654524
[patent_doc_number] => 20160000668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'AGENT FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBRES'
[patent_app_type] => utility
[patent_app_number] => 14/851055
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5628
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851055
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851055 | AGENT FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBRES | Sep 10, 2015 | Abandoned |
Array
(
[id] => 10653970
[patent_doc_number] => 20160000114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'TRANSPARENT AND TRANSLUSCENT LIQUID FILLED CANDY; PROCESS OF MAKING THEREOF; SUGAR-FREE LIQUID EDIBLE COMPOSITION; AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/851045
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11347
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851045
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851045 | TRANSPARENT AND TRANSLUSCENT LIQUID FILLED CANDY; PROCESS OF MAKING THEREOF; SUGAR-FREE LIQUID EDIBLE COMPOSITION; AND USE THEREOF | Sep 10, 2015 | Abandoned |
Array
(
[id] => 12282979
[patent_doc_number] => 09931306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-03
[patent_title] => Methods and biocompatible compositions to achieve sustained drug release in the eye
[patent_app_type] => utility
[patent_app_number] => 15/509083
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 19
[patent_no_of_words] => 12283
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509083
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509083 | Methods and biocompatible compositions to achieve sustained drug release in the eye | Sep 7, 2015 | Issued |
Array
(
[id] => 11864652
[patent_doc_number] => 20170231937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING LEVODOPA, A DOPAMINE DECARBOXYLASE INHIBITOR AND A COMT INHIBITOR AND METHOD OF ADMINISTRATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/507959
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19935
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507959
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507959 | Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof | Sep 3, 2015 | Issued |
Array
(
[id] => 11941945
[patent_doc_number] => 20170246097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'TRANSPARENT COSMETIC AND PERSONAL CARE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/505195
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7442
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505195
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505195 | Transparent cosmetic and personal care compositions | Aug 27, 2015 | Issued |
Array
(
[id] => 12000028
[patent_doc_number] => 20170304182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'CONDITIONING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/507334
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28261
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507334
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507334 | CONDITIONING COMPOSITIONS | Aug 24, 2015 | Abandoned |
Array
(
[id] => 10705330
[patent_doc_number] => 20160051477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'Method for Administering Metformin'
[patent_app_type] => utility
[patent_app_number] => 14/832232
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2027
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832232
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832232 | Method for Administering Metformin | Aug 20, 2015 | Abandoned |
Array
(
[id] => 11031387
[patent_doc_number] => 20160228343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'ISOTROPIC, FLOWABLE, SKIN PH AQUEOUS CLEANSING COMPOSITIONS COMPRISING N-ACYL GLYCINATES AS PRIMARY SURFACTANTS'
[patent_app_type] => utility
[patent_app_number] => 14/832322
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11819
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832322
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832322 | Isotropic, flowable, skin pH aqueous cleansing compositions comprising N-acyl glycinates as primary surfactants | Aug 20, 2015 | Issued |
Array
(
[id] => 11677225
[patent_doc_number] => 09675735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Catheters having an antimicrobial treatment'
[patent_app_type] => utility
[patent_app_number] => 14/831243
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 2137
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831243
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831243 | Catheters having an antimicrobial treatment | Aug 19, 2015 | Issued |
Array
(
[id] => 14323901
[patent_doc_number] => 10292943
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Delivery of bioactive, nanoencapsulated antioxidants
[patent_app_type] => utility
[patent_app_number] => 15/502415
[patent_app_country] => US
[patent_app_date] => 2015-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10153
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502415
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502415 | Delivery of bioactive, nanoencapsulated antioxidants | Aug 9, 2015 | Issued |
Array
(
[id] => 10692296
[patent_doc_number] => 20160038442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'MATERIALS AND METHODS FOR CONTROLLING INFECTIONS WITH NEGATIVE PRESSURE WOUND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/815966
[patent_app_country] => US
[patent_app_date] => 2015-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4024
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14815966
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/815966 | MATERIALS AND METHODS FOR CONTROLLING INFECTIONS WITH NEGATIVE PRESSURE WOUND THERAPY | Jul 31, 2015 | Abandoned |
Array
(
[id] => 11330904
[patent_doc_number] => 09522135
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-20
[patent_title] => 'Formulation of indomethacin'
[patent_app_type] => utility
[patent_app_number] => 14/810240
[patent_app_country] => US
[patent_app_date] => 2015-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 42155
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14810240
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/810240 | Formulation of indomethacin | Jul 26, 2015 | Issued |
Array
(
[id] => 11935094
[patent_doc_number] => 20170239243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'METHOD OF INCREASING BIOAVAILABILITY AND/OR PROLONGING OPHTHALMIC ACTION OF A DRUG'
[patent_app_type] => utility
[patent_app_number] => 15/329824
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14124
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329824
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329824 | Method of increasing bioavailability and/or prolonging ophthalmic action of a drug | Jul 23, 2015 | Issued |
Array
(
[id] => 11986620
[patent_doc_number] => 20170290774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'NEUROKININ-1 RECEPTOR ANTAGONIST COMPOSITION FOR TREATMENT OF DISEASES AND CONDITIONS OF THE RESPIRATORY TRACT'
[patent_app_type] => utility
[patent_app_number] => 15/328825
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13854
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328825
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328825 | NEUROKININ-1 RECEPTOR ANTAGONIST COMPOSITION FOR TREATMENT OF DISEASES AND CONDITIONS OF THE RESPIRATORY TRACT | Jul 23, 2015 | Abandoned |
Array
(
[id] => 10790179
[patent_doc_number] => 20160136335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'ENHANCEMENT OF ANTIMICROBIAL SILVER, SILVER COATINGS, OR SILVER PLATINGS'
[patent_app_type] => utility
[patent_app_number] => 14/806554
[patent_app_country] => US
[patent_app_date] => 2015-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22725
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14806554
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/806554 | Enhancement of antimicrobial silver, silver coatings, or silver platings | Jul 21, 2015 | Issued |
Array
(
[id] => 10443148
[patent_doc_number] => 20150328160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'REHYDRATABLE PHARMACEUTICAL PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/804474
[patent_app_country] => US
[patent_app_date] => 2015-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6543
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14804474
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/804474 | REHYDRATABLE PHARMACEUTICAL PRODUCT | Jul 20, 2015 | Abandoned |
Array
(
[id] => 10435672
[patent_doc_number] => 20150320684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'REHYDRATABLE PHARMACEUTICAL PRODUCT'
[patent_app_type] => utility
[patent_app_number] => 14/804520
[patent_app_country] => US
[patent_app_date] => 2015-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6545
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14804520
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/804520 | Rehydratable pharmaceutical product | Jul 20, 2015 | Issued |
Array
(
[id] => 10662145
[patent_doc_number] => 20160008288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'Controlled Release Compositions'
[patent_app_type] => utility
[patent_app_number] => 14/796248
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15769
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796248 | Controlled release compositions | Jul 9, 2015 | Issued |